A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

Not Applicable

Completed

• Conditions: Metabolic Syndrome; Diabetes Mellitus, Type 2; Insulin Resistance
• Interventions: Behavioral: Standard DPP; Behavioral: Enhanced DPP

• Registration Number: NCT02266576
• Lead Sponsor: Stanford University

Brief Summary

The goal of the proposed research is to identify effective patient-centered strategies to prevent diabetes in high-risk populations in real world settings. The investigators will accomplish this by conducting a randomized controlled trial comparing an enhanced Diabetes Prevention Program addressing psychosocial stressors to a standard version in a high-risk population of urban American Indian and Alaska Native people within a primary care setting.

Detailed Description

The goal of the proposed research is to identify effective patient-centered strategies to prevent diabetes in high-risk populations in real world settings. The investigators will accomplish this by conducting a randomized controlled trial comparing an enhanced Diabetes Prevention Program addressing psychosocial stressors to a standard version in a high-risk population of urban American Indian and Alaska Native peoples within a primary care setting. Diabetes is disproportionately prevalent among low-socioeconomic status and racial/ethnic minority populations in the US. The high prevalence of psychosocial stressors such as depression, discrimination, and exposure to trauma among these populations contributes to the high prevalence of diabetes and interferes with successful completion of lifestyle interventions. The investigators hypothesize that a DPP that directly addresses these psychosocial stressors will be superior to the standard DPP in addressing this disparity in diabetes.

Study Timeline

• Study First Submitted: 2014-10-13
• Study First Submitted QC: 2014-10-16
• Study First Posted: 2014-10-17
• Study Start: 2015-06
• Primary Completion: 2017-08-30
• Study Completion: 2017-08-30
• Status Verified: 2019-12
• Results First Submitted: 2019-12-09
• Results First Submitted QC: 2019-12-09
• Last Update Submitted: 2019-12-09
• Results First Posted: 2020-01-02
• Last Update Posted: 2020-01-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 207

Inclusion Criteria

• Urban of Indigenous Ancestry from the Americas (North, Central and South America)

• Men and women

• BMI Between 30-55

• Not diagnosed with Type II Diabetes

• At least one of the following criterion

  1. Triglycerides: 150mg/dL or higher
  2. Reduced HDL: <40mg/dL (men); <50mg/dL (women)
  3. Blood pressure: >130/80 or current treatment with antihypertensives
  4. Fasting glucose: >100mg/dL

Read More

Exclusion Criteria

• Significant medical comorbidities, including uncontrolled metabolic disorders (e.g., thyroid, diabetes, renal, liver), unstable heart disease, heart failure, and ongoing substance abuse;
• On greater than 10 prescription medications.
• Psychiatric disorders requiring atypical antipsychotics or multiple medications;
• Inappropriate for moderate exercise according to the Revised Physical Activity Readiness Questionnaire;
• Pregnant, planning to become pregnant, or lactating;
• Family household member already enrolled in the study;
• Already enrolled or planning to enroll in a clinical trial that would limit full participation in the study;
• Resident of a long term care facility;
• Lack of spoken English by patient or a household member > 18 y who can serve as interpreter;
• Plans to move during the study period (9 months post-randomization);
• Investigator discretion for clinical safety or adherence reasons (e.g., unstable housing, chronic pain).

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Standard Diabetes Prevention Program (DPP)	Standard DPP	Participants receive Standard DPP over the course of 20 weeks.
Enhanced DPP	Enhanced DPP	Participants receive Standard DPP plus Enhanced DPP over the course of 20 weeks.
Enhanced DPP	Standard DPP	Participants receive Standard DPP plus Enhanced DPP over the course of 20 weeks.

Primary Outcome Measures

Name	Time	Method
Change From Baseline in Body Mass Index (BMI) Through Month 12	Change through month 12, with assessments at baseline, 6 months, and 12 months	BMI is measured as weight in kg divided by the square of height in meters.
Change From Baseline in the Quality of Life Short Form Survey (SF-12)	Change through month 12, with assessments at baseline, 6 months, and 12 months	SF-12 scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey to evaluate overall health-related quality of life. Answers are combined, scored and weighted into mental and physical functioning component scales. The scores for each scale range from 0 to 100. A higher value indicates a better quality of life of the patient.

Secondary Outcome Measures

Name	Time	Method
Change From Baseline in Food Frequency Questionnaire (FFQ) Score as a Measure of Healthy and Unhealthy Diet Choices	Change through month 12, with assessments at baseline, 6 months, and 12 months	The FFQ modified to incorporate culturally-relevant food choices (e.g. corn tortillas and frybread) was used. Food items were scored on a scale of 1 to 6 (6 corresponding to the greatest frequency of consumption), and categorized as "healthy," "unhealthy," and "undetermined" based on classifications previously determined by Teuful-Shone et al. "Healthy" foods were those recommended for increased intake (e.g. green leafy salad). "Unhealthy" foods were recommended for decreased intake (e.g. soft drinks), and all remaining foods were "undetermined." Healthy and unhealthy food scores (but not undetermined) were collected for this outcome measure. Scores were summed for a total score. Healthy food choices (6 questions) score range 3-36 (higher scores mean healthier diet). Unhealthy food choices (13 questions) score range: 13-78 (lower scores mean healthier diet).
Change From Baseline in the Center for Epidemiologic Studies - Depression Scale (CES-D) as a Measure of Mental Health Symptoms	Change through month 12, with assessments at baseline, 6 months, and 12 months	The CES-D (Radloff, 1977) is a 20-item, self-report scale designed to assess the presence and severity of depressive symptoms over the past week. The total range is 0-80, with higher scores reflecting more severe depression symptoms.
Change From Baseline in Physical Activity Measured in Metabolic Equivalents (MET) Per Week	Change through month 12, with assessments at baseline, 6 months, and 12 months	MET is a term used to represent the intensity of exercise. A MET is the ratio of the rate of energy expended during an activity to the rate of energy expended at rest. At least 1000 MET minutes per week are needed to lower the risk of disease.; * 1 minute of light-intensity activities = 1.1 MET to 2.9 METs; * 1 minute of moderate-intensity activities = 3.0 to 5.9 METs; * 1 minute of vigorous-intensity activities = 6.0 METs or more
Change in From Baseline in Empowerment	Change through month 12, with assessments at baseline, 6 months, and 12 months	The Growth and Empowerment Measure (GEM) was developed to measure change in dimensions of empowerment as defined and described by Aboriginal Australians who participated in the Family Well Being programme. The GEM has two components. The 14-item Emotional Empowerment Scale has a range of 12-60, with higher scores corresponding to more ability to feel and show the signs of empowerment . The 12-item Scenarios scale has a range of 12-84, with higher scores corresponding to better emotional empowerment in different scenarios.

Trial Locations

Locations (2)

Timpany Center of San Jose State University; 🇺🇸 San Jose, California, United States

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States